Section Head of Microbiology
Cleveland Clinic
Disclosure(s): Abbott: Grant/Research Support; Altona: Grant/Research Support; BD: Grant/Research Support; bioMerieux: Grant/Research Support; Cepheid: Grant/Research Support; Cleveland Diagnostics: Grant/Research Support; HelixBind: Grant/Research Support; Hologic: Grant/Research Support; Luminex/Diasorin: Grant/Research Support; Meridian: Grant/Research Support; Next Gen Diagnostics: Board Member, Ownership Interest; Pattern Bio: Grant/Research Support; Qiagen: Grant/Research Support; Q-Linea: Grant/Research Support; Rapid Diagnostics: Grant/Research Support; Renascent Diagnostics: Advisor/Consultant, Financial payments, Ownership Interest; Roche: Grant/Research Support; Selux Diagnostics: Grant/Research Support; Thermo Fisher: Grant/Research Support; Vela Diagnostics: Grant/Research Support
Dr. Daniel Rhoads practices laboratory medicine at Cleveland Clinic in Cleveland, Ohio, where he serves as Head of the Microbiology Section in the Department of Laboratory Medicine. His clinical microbiology interests include the development, evaluation, and use of novel infectious disease diagnostic tools for the detection and characterization of pathogens.